Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federal register

Showing results (621-630 of 5,445) with videos related to

Pageof 545
Sort By:
Federal Register|January 5, 2002
Prevention of alcohol misuse and prohibited drug use in transit operations. Final rule
Federal Register|January 5, 2002
Listed chemicals; establishment of non-regulated transactions in anhydrous hydrogen chloride. Final rule confirmation
Federal Register|January 5, 2002
Medicare program; replacement of reasonable charge methodology by fee schedules for parenteral and enteral nutrients, equipment, and supplies. Final rule
Federal Register|January 5, 2002
Medicare program; payments for new medical services and new technologies under the acute care hospital inpatient prospective payment system. Final rule
Federal Register|February 7, 2002
Amendment of regulations regarding certain label statements on prescription drugs. Final rule
Federal Register|November 29, 2001
Food labeling: health claims; plant sterol/stanol esters and coronary heart disease. Interim final rule; notice of extension of period for issuance of final rule
Federal Register|January 5, 2002
Medicare program; announcement of the calendar year 2002 conversion factor for the hospital outpatient prospective payment system and a pro rata reduction on transitional pass-through payments. Final rule
Federal Register|November 7, 2000
Medicare program; Medicare+Choice program. Health Care Financing Administration (HCFA), HHS. Final rule with comment period
Federal Register|November 7, 2000
Medicare program; prospective payment system for home health agencies. Health Care Financing Administration (HCFA), HHS. Final rule
Federal Register|November 7, 2000
Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; amendment of final monograph for OTC antitussive drug products. Food and Drug Administration, HHS. Final rule
Pageof 545

Showing results (621-630 of 5,445) with videos related to

Sort By:
Pageof 545
Federal Register|January 5, 2002
Prevention of alcohol misuse and prohibited drug use in transit operations. Final rule
Federal Register|January 5, 2002
Listed chemicals; establishment of non-regulated transactions in anhydrous hydrogen chloride. Final rule confirmation
Federal Register|January 5, 2002
Medicare program; replacement of reasonable charge methodology by fee schedules for parenteral and enteral nutrients, equipment, and supplies. Final rule
Federal Register|January 5, 2002
Medicare program; payments for new medical services and new technologies under the acute care hospital inpatient prospective payment system. Final rule
Federal Register|February 7, 2002
Amendment of regulations regarding certain label statements on prescription drugs. Final rule
Federal Register|November 29, 2001
Food labeling: health claims; plant sterol/stanol esters and coronary heart disease. Interim final rule; notice of extension of period for issuance of final rule
Federal Register|January 5, 2002
Medicare program; announcement of the calendar year 2002 conversion factor for the hospital outpatient prospective payment system and a pro rata reduction on transitional pass-through payments. Final rule
Federal Register|November 7, 2000
Medicare program; Medicare+Choice program. Health Care Financing Administration (HCFA), HHS. Final rule with comment period
Federal Register|November 7, 2000
Medicare program; prospective payment system for home health agencies. Health Care Financing Administration (HCFA), HHS. Final rule
Federal Register|November 7, 2000
Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; amendment of final monograph for OTC antitussive drug products. Food and Drug Administration, HHS. Final rule
Pageof 545